Neurological Biomarkers Market - Global Forecast 2026-2032

The neurological biomarkers market is at the forefront of significant healthcare transformation, shaping the way advanced diagnostics and precision medicine are delivered globally. As integration across research, clinical practice, and commercial operations broadens, senior leaders must respond nimbly to shifting science, emerging operational models, and dynamic international environments.

Market Snapshot: Neurological Biomarkers Market Growth

The Neurological Biomarkers Market is experiencing rapid expansion, rising from USD 11.74 billion in 2025 to USD 13.45 billion in 2026, propelled by sustained demand for precision neurology and translational diagnostics. Strong growth is reflected in a compound annual growth rate (CAGR) of 14.42%, with the overall market set to reach USD 30.15 billion by 2032.

Scope & Segmentation of the Neurological Biomarkers Market

This report presents a thorough segmentation and analysis of the neurological biomarkers market, supporting executive strategy across several critical dimensions:

Biomarker Types: Cellular, genetic, imaging-derived, metabolic, and protein-based biomarkers each deliver distinct advantages to clinical, analytic, and operational use cases, often working together to enhance outcome robustness and expand scientific applicability.
Technology Platforms: Enzyme-Linked Immunosorbent Assay (ELISA); advanced imaging modalities including MRI, CT, PET, and fNIRS; mass spectrometry; next-generation sequencing; and Polymerase Chain Reaction (PCR) technologies support varied applications, chosen based on biological targets and analytical validation requirements.
Applications: Clinical diagnostics, patient monitoring, drug development, prognostic modeling, and discovery research all drive market momentum, each presenting challenges related to accuracy, workflow integration, and reproducibility.
End Users: Contract research organizations, diagnostic labs, hospitals, clinics, pharmaceutical firms, biotech companies, and academic research institutes depend on flexible, compliant, and scalable solutions for evolving operational needs.
Regional Analysis: Coverage encompasses the Americas, Europe, Middle East & Africa, and Asia-Pacific, where differences in regulatory standards, translational approaches, and health systems produce distinct adoption pathways and innovation cycles.

Key Takeaways for Decision-Makers

Neurological biomarkers are driving advances in early disease identification, patient stratification, and reliable endpoints for clinical research and care optimization.
Regulatory and reimbursement requirements increasingly demand demonstrated analytic validity, clinical efficacy, and real-world impact for market entry and expansion.
Technology trends center on integrating multimodal analytics, applying machine learning algorithms, and developing sensitive assays, thereby improving predictive value and reproducibility in neurodiagnostics.
Successful adoption depends on resilient supply chains, standardization of platforms, and collaborative clinical validation, which enhance market confidence and scalability for all stakeholders.
Regional ecosystems uniquely impact innovation: North America leads in translation to practice, Europe excels at large-scale data harmonization, and Asia-Pacific leverages centralized healthcare to execute broad cohort studies efficiently.

Tariff Impact on the Neurological Biomarkers Market

Recent tariff structures and evolving global trade regulations have heightened operational complexities, especially in sourcing reagents and critical instrumentation and maintaining just-in-time logistics. Organizations are countering these pressures by diversifying supplier bases, shifting select manufacturing closer to home, and rethinking international collaborations. Digital and cloud-based solutions are gaining traction, reducing geographic dependencies and reinforcing supply continuity strategies across the neurological biomarkers market.

Methodology & Data Sources

The analysis presented in this report draws from structured interviews with key participants in the neurological biomarkers sector, comprehensive literature evaluations, regulatory documents, and triangulation of independent datasets. The methodology emphasizes analytical transparency and provides reproducibility checkpoints, with all limitations explicitly qualified and addressed through ongoing updates as fresh validation data become available.

Why This Report Matters

Offers actionable insights to align commercial, regulatory, and operational frameworks in a complex market landscape for neurological biomarkers.
Clarifies how current scientific and technological developments shift the competitive and regulatory dynamics affecting diagnostics, pharmaceutical, and research sectors.
Equips senior management with tools for assessing supply chain robustness, developing strategic partnerships, and evaluating technology adoption in real-world clinical settings.

Conclusion

The neurological biomarkers market sits at a pivotal crossroads where technical capability and strategic alliances are crucial for turning innovations into practical clinical tools. Coordinated execution, cross-industry partnership, and operational diligence will underpin sustained progress and commercial success.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Neurological Biomarkers Market, by Biomarker Type

8.1. Cellular
8.2. Genetic
8.3. Imaging
8.4. Metabolite
8.5. Protein

9. Neurological Biomarkers Market, by Technology Platform

9.1. Enzyme-Linked Immunosorbent Assay
9.2. Imaging Techniques
9.2.1. Computed Tomography
9.2.2. Functional Near-Infrared Spectroscopy
9.2.3. Magnetic Resonance Imaging
9.2.4. Positron Emission Tomography
9.3. Mass Spectrometry
9.4. Next-Generation Sequencing
9.4.1. RNA Sequencing
9.4.2. Targeted Resequencing
9.4.3. Whole Genome Sequencing
9.5. Polymerase Chain Reaction

10. Neurological Biomarkers Market, by Application

10.1. Diagnostics
10.2. Drug Development
10.3. Monitoring
10.4. Prognostics
10.5. Research

11. Neurological Biomarkers Market, by End User

11.1. Contract Research Organizations
11.2. Diagnostic Laboratories
11.3. Hospitals & Clinics
11.4. Pharmaceutical & Biotechnology Companies
11.5. Research Institutes

12. Neurological Biomarkers Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Neurological Biomarkers Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Neurological Biomarkers Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Neurological Biomarkers Market
16. China Neurological Biomarkers Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Alto Neuroscience,Inc.
17.7. APIS Assay Technologies Limited
17.8. Augurex Life Sciences Corp
17.9. Bio-Rad Laboratories, Inc.
17.10. BioAgilytix
17.11. Biocrates Life Sciences AG
17.12. Biofourmis Inc.
17.13. Biognosys AG
17.14. BIOINFRA Life Science Inc.
17.15. BioStarks
17.16. BioVision Inc.
17.17. Charles River Laboratories, Inc.
17.18. Clarigent Corporation
17.19. EKF Diagnostics Holdings PLC
17.20. Elo Health, Inc.
17.21. F. Hoffmann-La Roche, Ltd.
17.22. Merck KgaA
17.23. Nightingale Health Plc
17.24. Owkin Inc.
17.25. Owlstone Medical Limited
17.26. PerkinElmer, Inc.
17.27. Personalis, Inc.
17.28. Proteomedix AG
17.29. QIAGEN GmbH
17.30. Renalytix PLC
17.31. Siemens Healthcare GmbH
17.32. Sino Biological Inc.
17.33. Thermo Fisher Scientific, Inc.
17.34. VivoSense, Inc.

List of Figures

FIGURE 1. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY GENETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY GENETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY GENETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY METABOLITE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY METABOLITE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY METABOLITE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROTEIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY FUNCTIONAL NEAR-INFRARED SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY FUNCTIONAL NEAR-INFRARED SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY FUNCTIONAL NEAR-INFRARED SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TARGETED RESEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TARGETED RESEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TARGETED RESEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. EUROPE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. EUROPE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 121. EUROPE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 122. EUROPE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 123. EUROPE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 134. AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 135. AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 136. AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 137. AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. ASEAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. ASEAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 149. ASEAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 150. ASEAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 151. ASEAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 152. ASEAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. ASEAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. GCC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GCC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 156. GCC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 157. GCC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 158. GCC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 159. GCC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. GCC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. BRICS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. BRICS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 170. BRICS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 171. BRICS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 172. BRICS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 173. BRICS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. BRICS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. G7 NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. G7 NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 177. G7 NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 178. G7 NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 179. G7 NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 180. G7 NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. G7 NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. NATO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. NATO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 184. NATO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 185. NATO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 186. NATO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 187. NATO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. NATO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 198. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 199. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 200. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 201. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 202. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Neurological Biomarkers market report include:

Abbott Laboratories
Alto Neuroscience,Inc.
APIS Assay Technologies Limited
Augurex Life Sciences Corp
Bio-Rad Laboratories, Inc.
BioAgilytix
Biocrates Life Sciences AG
Biofourmis Inc.
Biognosys AG
BIOINFRA Life Science Inc.
BioStarks
BioVision Inc.
Charles River Laboratories, Inc.
Clarigent Corporation
EKF Diagnostics Holdings PLC
Elo Health, Inc.
F. Hoffmann-La Roche, Ltd.
Merck KgaA
Nightingale Health Plc
Owkin Inc.
Owlstone Medical Limited
PerkinElmer, Inc.
Personalis, Inc.
Proteomedix AG
QIAGEN GmbH
Renalytix PLC
Siemens Healthcare GmbH
Sino Biological Inc.
Thermo Fisher Scientific, Inc.
VivoSense, Inc.

Table Information

Report Attribute	Details
No. of Pages	181
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 13.45 Billion
Forecasted Market Value ( USD ) by 2032	$ 30.15 Billion
Compound Annual Growth Rate	14.4%
Regions Covered	Global
No. of Companies Mentioned	31

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Neurological Biomarkers Market Growth

Scope & Segmentation of the Neurological Biomarkers Market

Key Takeaways for Decision-Makers

Tariff Impact on the Neurological Biomarkers Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Brain Biomarkers Market - Global Forecast 2026-2032

Central Nervous System Biomarkers Market - Global Forecast 2025-2032

Neurological Biomarkers Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2025-2033

Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report

Biomarkers: Discovery Techniques and Applications - A Global Market Overview